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Abstract
Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that causes birth defects in newborns and life-threatening
complications in immunocompromised individuals. Among all human herpesviruses, HCMV contains a much larger dsDNA
genome within a similarly-sized capsid compared to the others, and it was proposed to require pp150, a tegument protein
only found in cytomegaloviruses, to stabilize its genome-containing capsid. However, little is known about how pp150
interacts with the underlying capsid. Moreover, the smallest capsid protein (SCP), while dispensable in herpes simplex virus
type 1, was shown to play essential, yet undefined, role in HCMV infection. Here, by cryo electron microscopy (cryoEM), we
determine three-dimensional structures of HCMV capsid (no pp150) and virion (with pp150) at sub-nanometer resolution.
Comparison of these two structures reveals that each pp150 tegument density is composed of two helix bundles connected
by a long central helix. Correlation between the resolved helices and sequence-based secondary structure prediction maps
the tegument density to the N-terminal half of pp150. The structures also show that SCP mediates interactions between the
capsid and pp150 at the upper helix bundle of pp150. Consistent with this structural observation, ribozyme inhibition of
SCP expression in HCMV-infected cells impairs the formation of DNA-containing viral particles and reduces viral yield by
10,000 fold. By cryoEM reconstruction of the resulting ‘‘SCP-deficient’’ viral particles, we further demonstrate that SCP is
required for pp150 functionally binding to the capsid. Together, our structural and biochemical results point to a
mechanism whereby SCP recruits pp150 to stabilize genome-containing capsid for the production of infectious HCMV
virion.
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Introduction
Human cytomegalovirus (HCMV), the prototype of betaher-
pesvirus subfamily of the Herpesviridae, is a leading viral cause of
birth abnormalities and a major life-threatening pathogen in AIDS
and organ transplant patients [1]. HCMV virion shares a common
architecture with other herpesviruses and consists of a polymor-
phic envelope, a tegument compartment and an icosahedral
nucleocapsid enclosing a linear dsDNA genome. The HCMV
genome is the largest amongst that of all human herpesviruses, and
encodes a remarkable number of conserved proteins, as well as
unique envelope and tegument proteins that lack homologs in
alpha- or gammaherpesviruses [2]. The HCMV capsid shell,
similar to those of herpes simplex virus type 1 (HSV-1) and
Kaposi’s sarcoma-associated herpesvirus (KSHV), is composed of
four major proteins: the major capsid protein (MCP; encoded by
UL86) [3], the minor capsid protein (mCP; encoded by UL85), the
mCP binding protein (mC-BP; encoded by UL46) [4], and the
smallest capsid protein (SCP; encoded by UL48.5) [5,6]. All
herpesvirus capsids studied to date share a T = 16 icosahedral
assembly with pentons (MCP pentomers), hexons (hexamers of
MCP), connecting triplexes (heterotrimers of two mCP and one
mC-BP), and SCP attached to the tip of each MCP [7,8,9,10,11].
While the other three capsid structural proteins are conserved,
SCP is very divergent in size, amino acid sequence and function
among different herpesviruses. In HCMV, SCP was shown to be
essential for virus growth [12], but its function is still unknown.
CryoEM reconstruction also revealed different patterns of
association between capsid and overlying tegument proteins in
CMV and HSV. In HCMV, a layer of highly organized
filamentous density of tegument proteins is attached to the
pentons, hexons and triplexes of the underlying nucleocapsid
[13]. The three-dimensional (3D) reconstruction of the simian
cytomegalovirus (SCMV) capsid isolated from the cytoplasm of
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infected cells also revealed tegument proteins attached to the
capsid [8], similar to HCMV. In contrast, HSV-1 ordered
tegument proteins only bind pentons and those triplexes
surrounding pentons [14,15,16]. These observations indicate that
viral proteins overlying the conserved capsid, such as tegument
and envelope proteins, have evolved to have virus-specific
structural and functional roles. Recently, biochemical and
structural studies have assigned pp150 to the ordered filamentous
tegument densities of CMV virion and suggested its function in
stabilizing the dsDNA-filled C capsid [17,18], but more structural
details are needed to fully understand the molecular interactions
between pp150 and capsid proteins.
Here, we report the 3D structures of HCMV capsid and intact
HCMV virion at 6 A˚ and 9 A˚ resolution, respectively (Figure S1).
Comparison of the capsid and virion structures reveals, at a
secondary-structure level, that SCP mediates interactions between
the capsid and tegument protein pp150. By constructing a
ribozyme that inhibits SCP expression in HCMV-infected cells,
and cryoEM reconstruction of the resulting ‘‘SCP-deficient’’ viral
particles, we further demonstrate that SCP is required for pp150
binding to capsid and its absence results in only viral particles
devoid of the DNA genome, thus revealing why SCP is essential
for HCMV infection.
Results
CryoEM structural determination
Due to the large size of CMV particles and the difficulties to
purify them, resolutions of previous cryoEM reconstructions were
limited [8,10,13,19]. In this study, highly purified HCMV capsid
(no tegument, Figure 1A) and the intact virion (containing
tegument proteins, Figure 1B) were obtained and imaged in a
300 kV Titan Krios high-resolution electron microscope. 3D
reconstructions of HCMV capsid and virion were obtained at 6 A˚
and 9 A˚ resolution, respectively (Figure S1). The improved
structures are a result of an exhaustive effort of processing more
than 37,000 capsid images and 56,000 virion images. At these
sub-nanometer resolutions, secondary structural elements, partic-
ularly a-helices, can be identified, as exemplified by the close-up
views of a hexon in the capsid reconstruction (Figure 1C–E).
Molecular boundaries can be established, allowing us to describe
the interactions between the ordered tegument proteins and capsid
proteins at secondary-structure level for the first time.
Comparisons of 3D reconstructions of the capsid and the
virion
The 6 A˚ reconstruction of the HCMV capsid reveals the
molecular boundaries among the 150 hexons, 12 pentons and 320
triplexes in the T = 16 icosahedral particle (Figure 1C), allowing
identification of individual molecules. In particular, the upper
domain of an MCP monomer was extracted from a central hexon
(Figure 1F) and superimposed with the crystal structure of the
HSV-1 MCP upper domain (MCPud) (PDB accession code 1N07)
(Figure 1G) [20]. Except for very minor differences at the tip and
the outer surface of the subunits (arrow and arrowhead in
Figure 1G), excellent match of all the a-helices between HCMV
and HSV-1 MCPuds is observed, indicating that the bulk of
MCPud structure is conserved between the two viruses. This
match also demonstrates the high quality of the map.
In addition, the fitting reveals that SCP molecules were lost in
this highly purified capsid sample, probably due to the use of
detergent during all purification steps (see Experimental Proce-
dures). In gently prepared capsid preparations, SCP binds MCP at
the upper domain as shown in previous capsid reconstructions we
obtained [10,19]. The absence of SCP in the capsid reconstruction
provides the advantage to identify the molecular boundary
between SCP and MCP in the virion reconstruction (see below).
The 9 A˚ reconstruction of HCMV virion shows a layer of
filamentous tegument proteins bound to the capsid in an
icosahedrally ordered fashion, like a net enclosing the entire
capsid (Figure 1H). Three of these tegument densities sit on top of
each triplex, forming a ‘group-of-three’, and extend to the top of
the nearest subunits in the three surrounding capsomers. The
location and appearance of these tegument densities are similar to
those decorated by anti-pp150-antibodies [17,18]. In each
asymmetric unit of the herpesvirus capsid, there are six quasi-
equivalent triplexes, Ta, Tb, Tc, Td, Te and Tf (Figure 1I),
following the nomenclature of [21]. The group-of-three tegument
densities on triplexes Tb, Td and Te are the most similar in
structure. We averaged the densities within three cubes, each of
which contains one of these group-of-three tegument densities
(e.g., the region encompassing Te is outlined by the dashed square
in Figure 1I) to improve the signal/noise ratio (Figure 2A). Helices
in the tegument proteins can be resolved in the averaged density
(as illustrated in Figure 2E). The same cubic regions from the
capsid reconstruction were averaged for comparison (Figure 2B).
This comparison allowed us to differentiate densities of MCP and
triplexes from densities attributable to SCP and tegument proteins,
and subsequently to segment out SCP and the tegument densities.
The boundary between SCP and pp150 was established by
referring to our pervious SCP-containing capsid reconstruction
[19].
Structure of the capsid-interacting tegument protein,
pp150
The three tegument densities in the averaged group-of-three
exhibit a high level of similarity and appear nearly identical when
displayed side by side (Figure 2D). This structural similarity among
Author Summary
Human cytomegalovirus (HCMV) causes birth defects in
newborns and life-threatening complications in immuno-
compromised individuals, such as AIDS patients and organ
transplant recipients. The smallest capsid protein (SCP) –
only 8 kDa molecular mass as compared to the 155 kDa
major capsid protein – has been demonstrated to be
essential for HCMV growth, but is dispensable in herpes
simplex virus type 1. These seemingly contradictory
observations have been a paradox. Here, we solve this
paradox by high resolution cryo electron microscopy
(cryoEM), in conjunction with functional studies using
ribozyme inhibition. Our structural comparisons of HCMV
virion and capsid reveal molecular interactions at the
secondary structure level and suggest that SCP might
contribute to capsid binding of pp150, an essential,
cytomegalovirus-specific tegument protein. SCP-deficient
particles generated by ribozyme inhibition of SCP-expres-
sion in HCMV-infected cells show no pp150 tegument
density, demonstrating that SCP is required for the
functional binding of pp150 to the capsid. Our results
suggest that SCP recruits pp150 to stabilize the HCMV
nucleocapsid to enable encapsidation of the genome,
which is more densely packaged in HCMV than in other
herpesviruses. Overall, this study not only resolves the
above paradox, but also illustrates the passive acquisition
of a new, essential function by SCP in the production of
infectious HCMV virions.
SCP Mediates pp150 Binding in Cytomegalovirus
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the three tegument densities suggests that three copies of the same
tegument protein or protein complex associate with each triplex,
which differs from the situation in SCMV, where only two copies
of tegument densities were interpreted to bind to each triplex [8].
In each tegument density of HCMV, we resolved two helix
bundles, an upper one and a lower one, joined by a long central
helix (,67 A˚ in length). The upper helix bundle (UHB) is
composed of the central helix and five shorter surrounding helices.
The lower helix bundle (LHB) only has three short helices
surrounding the central helix (Figure 2E).
Previous studies of HCMV and SCMV particles have suggested
pp150 as one of the candidates for the capsid-interacting tegument
densities [8,13,18]. Secondary structure prediction indicates that
the C terminal half of pp150 is almost entirely coils, in contrast to
the N terminal half, which contains many helices (Figure 2F).
Among these predicted helices, the longest one has 47 residues
from a.a.195 to a.a.241 (Figure 2F), which would span ,70 A˚ as
each amino acid in an a-helix gives an axial distance of 1.5 A˚.
This ,70 A˚ length of the longest predicted helix and the
measured ,67 A˚ length of the central helix resolved in the
cryoEM density correlate well with each other, and both are more
than twice the length of any other predicted or resolved helices.
Moreover, there are eight other predicted major helices with more
than 3 helical turns (each turn = 3.6 a.a.) and their lengths (12–22
a.a.) also correlate with those of the eight shorter helices resolved
in the tegument density. Therefore, we conclude that the resolved
tegument density is contributed only by the N-terminal half of
pp150 molecule, while the C-terminal half of pp150 may be
disordered or flexible. This conclusion is consistent with previous
biochemical data showing that N-terminal segment of SCMV
pp150 was both necessary and sufficient to bind either SCMV or
HCMV capsid in vitro [22].
SCP mediates interactions between pp150 and the
capsid
We further identified the interface between the tegument
density and the capsid. At one end of pp150, its LHB has direct
contacts with the triplex (Figure 3A–C). At the other end, pp150
UHB interacts with the capsomer through one of its five short
helices (arrowhead in Figure 3D and 3E). This interaction appears
to be mediated by the 8 kDa SCP molecule, which is situated in
the cleft formed by the pp150 UHB and the upper domain of
MCP (Figure 3D–E). The direct contact between the densities
assigned to pp150 and SCP suggests direct binding of the two
molecules, although at this resolution, one can’t rule out the
unlikely possibility that binding of SCP to MCPud can in theory
change conformation of MCPud, causing it to bind to pp150
directly.
Confirmation of the role of SCP by ribozyme inhibition
To assess the functional significance of SCP in mediating pp150
binding to the capsid, we constructed a cell line expressing a
ribozyme that inhibits the expression of SCP when the cell line is
infected by HCMV. Then, we determined the consequence of this
inhibition on pp150-binding to the capsid by cryoEM analyses of
viral particles harvested from this cell line.
We constructed a ribozyme, called SCP1, by covalently linking
the 39 terminus of a previously established M1GS ribozyme
variant (V482) [23] to an 18-nt guide sequence complementary to
the targeted HCMV SCP mRNA sequence. Two other ribozymes,
SCP2 and TK1, were also designed and used as controls. SCP2
contains the same guide sequence as SCP1 but has multiple point
mutations at the catalytic P4 domain that abolish its catalytic
activity [24], thus serving as a control for the antisense effect in our
experiments. TK1 targets the mRNA of thymidine kinase (TK) of
HSV-1 and serves as a control to determine whether M1GS RNA
with an incorrect guide sequence could target SCP mRNA in
tissue culture. We subsequently constructed cell lines expressing
each of these three M1GS ribozymes and carried out the following
three experiments.
First, we analyzed SCP mRNA expression in HCMV-infected
cells by Northern blotting, using the level of viral immediate-early
(IE) 5-kb mRNA as an internal control (Figure 4A). Based on
radioactivity of 32P-labeled probes, we estimated that target
mRNA expression level was reduced by 9868%, 764%, and
363% (average of three experiments) in cells expressing SCP1,
SCP2 and TK1, respectively. Furthermore, the protein level of
SCP, as determined by Western analyses with the MCP protein
level as the internal and loading control, was reduced by 9769%,
865%, and 261% in cells expressing SCP1, SCP2, and TK1,
respectively (Figure 4C, lanes 9–12). Thus, targeted cleavage of
SCP mRNA by ribozyme SCP1 significantly reduced SCP
expression in cells expressing SCP1, but not in cell lines expressing
both control ribozymes. The low level of inhibition observed in
SCP2-expressing cells was probably due to an antisense effect, as
SCP2 has a target-binding affinity similar to that of SCP1 but is
catalytically inactive.
Second, we assessed the effect of SCP-inhibition in viral yield by
measuring viral titers of stocks from HCMV-infected cells that
express the ribozymes. At 5 days post-infection, viral yields were
reduced by at least 10,000-fold in cells expressing SCP1, whereas
no significant reduction was observed in cells expressing SCP2 or
TK1 (Figure 4B).
Third, to uncover the structural basis of the reduction of viral
yield due to SCP inhibition, we imaged viral particles isolated from
SCP1-expressing cells by cryoEM and compared its 3D structure
with that of the wild-type HCMV virion. Using MCP as the
internal and loading control, Western analyses showed that SCP
was hardly detected in HCMV particles isolated from SCP1-
expression cells but was readily found in viral particles isolated
from cells that did not express any ribozymes or expressed control
ribozymes SCP2 or TK1 (Figure 4C, lanes 13–15). CryoEM
images of wild-type HCMV virion have the characteristic
‘‘fingerprint’’ appearance (Figure 1B), which is a hallmark of
Figure 1. Comparison of 3D reconstructions of the HCMV capsid and virion. (A, B) CryoEM images of HCMV capsid (A) and virion (B). (C)
Radially colored surface representation of the 3D reconstruction of the capsid at 6 A˚ resolution viewed along a 3-fold axis. Capsomers in an
asymmetric unit, including a penton and three hexons, are labeled as ‘‘5’’, ‘‘C’’, ‘‘P’’ and ‘‘E’’, respectively, as in the nomenclature of [39]. (D, E) Close-up
views of the C hexon demarked in the capsid reconstruction, viewed from outside (D) or inside (E) of the capsid. An a-helix with typical sausage shape
is denoted in (E). (F, G) MCPud. The density map of the MCPud denoted by the square in (D) was extracted and radially colored (F). In (G), the same
MCPud is shown in semi-transparent yellow and superimposed with the HSV-1 MCPud atomic model (magenta ribbon). Note all helices match in the
two structures but the loops at the tip (arrow) and at the outer surface (arrowhead) of HSV-1 MCPud do not fit the cryoEM density map of HCMV
MCPud, suggesting possible structural differences. (H) Radially colored surface representation of the 3D reconstruction of the HCMV virion viewed
along a 3-fold axis. (I) Zoom-in view of the area denoted in (H). Structural components in an asymmetric unit are labeled, including a penton (‘‘5’’),
three hexons (‘‘C’’, ‘‘P’’ and ‘‘E’’), and six triplexes (‘‘Ta’’, ‘‘Tb’’, ‘‘Tc’’, ‘‘Td’’, ‘‘Te’’ and ‘‘Tf’’). Dashed square demarcates a region encompassing Te that is
segmented out for averaging with similar regions around Tb and Td (see text and Figure 2).
doi:10.1371/journal.ppat.1003525.g001
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Figure 2. Structure of the capsid-interacting pp150 tegument protein. (A, B) Averaged density of the regions surrounding triplexes Tb, Td
and Te (as marked by the dashed square in Figure 1I) from the virion (A) or capsid (B) reconstructions. The two density maps are colored the same as
in Figure 1H or 1C. (C) SCP (light blue) and tegument (green, magenta and cyan) densities segmented from the virion densities of (A) superimposed
on the capsid densities (yellow) of (B). (D) Views of the three tegument densities of (C) after alignment to each other. The most prominent feature is
the sausage-shaped densities due to helices. The dashed line denotes the boundary of the upper helix bundle (UHB) and the lower helix bundle
(LHB). (E) The cyan tegument density in (D) is shown semi-transparently and superimposed with cylinders representing helices. Helices in the upper
helix bundle (magenta) and lower helix bundle (cyan) are connected by a 67 A˚-long central helix (CH, red). (F) Secondary structure prediction of
pp150 based on its amino acid sequence. The putative location for the long central helix identified in (E) is indicated by the red line.
doi:10.1371/journal.ppat.1003525.g002
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encapsidated genomic dsDNA [14,25]. In contrast, none of the
cryoEM images of particles harvested from the SCP1-expressing
cell culture media shows a fingerprint pattern (Figure 5A),
indicating that they do not contain viral DNA genome and are
thus non-infectious. The existence of non-infectious enveloped
particles (NIEPs) in this preparation indicates that the inhibition of
SCP expression does not prevent capsid assembly and envelop-
ment. Furthermore, 3D reconstruction at 20 A˚ resolution of these
SCP-deficient particles shows a structure with no visible tegument
densities bound to the capsid (Figure 5C). In contrast, reconstruc-
tion of wild-type virion at the same resolution clearly shows
tegument densities interacting with the underlying capsid
(Figure 5B). This result clearly demonstrates that SCP is required
for the functional binding of pp150 to capsid. Considering that
pp150 may function in stabilizing the dsDNA-filled C capsid
[17,18], we reason that, in the absence of SCP, pp150 can no
longer form the stabilizing network of density surrounding the
capsid, thus preventing the formation of DNA-containing virion
(Fig. 5A). However, we cannot rule out the possibility that the lack
of DNA in the SCP-deficient particle and failure to bind pp150
are two unrelated, downstream consequences of lacking SCP. It is
also noteworthy that, although the absence of SCP prevents pp150
from binding to the capsid with icosahedral symmetry, it does not
necessarily eliminate binding of pp150 to the capsid triplex in a
non-icosahedrally ordered fashion, which could have also
produced a cryoEM map without visible pp150 densities.
Discussion
As mentioned above, among all human herpesviruses, HCMV
has the largest dsDNA genome contained within a capsid of
similar size. As a result, the distance between adjacent dsDNA
duplex in HCMV capsid is 23 A˚ [26], as compared to 26 A˚ and
25 A˚ for those in alphaherpesvirus [14] and gammaherpesvirus
[27], respectively. It is conceivable that the electrostatic repulsion
of the more densely packed genome in HCMV would exert higher
Figure 3. SCP mediates pp150 binding to the capsid. (A–C) Density slices showing that pp150 tegument protein binds to the capsid triplex
with its LHB (lower helix bundle). The binding sites on the triplex are labeled with ‘‘*’’. The LHB of one molecule in the group-of-three tegument
densities also has contact with MCP. It is labeled with ‘‘#’’. (D) A close-up, top view of the region demarcated by the dashed square in the inset,
revealing the interactions between pp150 (cyan), SCP (light blue) and MCPud (yellow). (E) Same as in (D) but viewed from the direction indicated by
the eye symbol in (D). Arrow in both (D) and (E) points to the a-helix in pp150 UHB (upper helix bundle) that interacts with SCP.
doi:10.1371/journal.ppat.1003525.g003
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pressure to the capsid shell, possibly rendering the DNA-
containing capsid (i.e., ‘‘C capsid’’) unstable. Indeed, throughout
our cryoEM imaging of the HCMV capsid preparation, not a
single intact DNA-containing capsid was observed among the over
30,000 particle images we examined (Figure 1A), in stark contrast
to the situations of alphaherpesvirus [25] and gammaherpesvirus
[27] where C capsids can be readily purified from the nuclei of
infected cells. Upon tegumentation, including the addition of
pp150, DNA-containing nucleocapsids are stabilized and thus are
routinely found in HCMV virion preparations (Figure 1B).
Of the capsid structural proteins, SCP is the least conserved
across different herpesviruses in size, amino acid sequence, and
function. For example, the HSV-1 SCP has a molecular weight of
12 kDa and is dispensable for virus growth in cell culture [28].
The 16 kDa KSHV SCP is the largest and is essential for capsid
assembly [29,30]. The 8 kDa HCMV SCP is the smallest and is
essential for virus growth [12], but its functional role is a long-
standing mystery. Here, by using SCP-targeting ribozyme and
cryoEM reconstruction, we provide the first evidence that SCP is
required to stabilize DNA-containing HCMV capsids, and that it
may do so by directly or indirectly mediating pp150 binding to the
capsid. To our best knowledge, this role is the only function of
HCMV SCP identified to date. This result, when considered
together with the absence of a pp150 homolog in both alpha- and
gammaherpesviruses, indicates that SCP of herpesviruses has
diverged in function though its location in different herpesviruses is
conserved. Perhaps, SCP has a yet unknown, non-essential
function conserved across all herpesviruses, but in HCMV, it is
re-utilized by pp150 as a partner to stabilize DNA-containing
capsid, an essential process for HCMV infection.
Taken into consideration the relatively small size and essential
function, HCMV SCP clearly provides a potential target for
intervention against HCMV infection. One possible way is to
design SCP-mimicking peptides that act as competitive inhibitors
of pp150 binding and functioning, thus preventing infectious viral
particle formation.
Materials and Methods
HCMV virion preparation
Human fibroblast MRC-5 cells were cultured in Dulbecco’s
Modified Eagle Medium (DMEM) plus 10% fetal bovine serum
(FBS). 20 flasks (175 cm2) of cells were grown to 90% confluence
and infected with HCMV strain AD169 at a multiplicity of
infection (MOI) of 0.1–1. At 6 days post infection, when half of the
cells were lysed, the media were collected and centrifuged at 10,
000 g for 15 min to remove cell debris. The clarified supernatant
was collected and centrifuged at 80, 000 g for 1 hr to pellet
HCMV virions. Pellets were resuspended in a total volume of 2 ml
phosphate buffered saline (PBS, pH 7.4) and loaded on a 15%–
50% (w/v) sucrose density gradient and sedimented at 100,000 g
for 1 hr. Usually we observe three light-scattering bands – top,
middle and bottom – containing mainly NIEPs, virions and dense
bodies, respectively. The middle band was collected and diluted in
PBS to a total volume of 13 ml. Virion particles were pelleted
again at 80,000 g for 1 hr and resuspended in 30 ml PBS for
cryoEM sample preparation.
HCMV capsid preparation
To obtain HCMV capsids, we infected 90% confluent MRC-5
cells at MOI = 5. At 3 days post infection, when cytopathic effect
reached 100%, cells were collected, pelleted by low-speed
centrifuge at 1000 g for 10 min, and washed with PBS. The
pellet was then resuspended in PBS containing 0.5% NP-40 (w/v)
and incubated on ice for 5 min. The mixture was centrifuged at
1000 g for 10 min to pellet cell nuclei. To break nuclear
membrane, the pellet was then resuspended in PBS, subjected to
three cycles of freezing (280uC, 10 min), thawing (37uC, 3 min)
and vortexing, passed through a 23 gauge hypodermic needle for
20 times, and incubated in PBS with 2% NP-40 overnight at 4uC.
The lysate was centrifuged at 1500 g for 5 min to remove large
debris and then sedimented through a 30% sucrose cushion at
100,000 g for 1 hr. The pellet was resuspended in PBS containing
2% NP-40, diluted to a final volume of 13 ml, and centrifuged
again at 70,000 g for 1 hr. The pelleted capsids were resuspended
in 30 ml PBS and used for cryoEM sample preparation.
Construction and in vitro characterization of SCP-
targeting and control ribozymes
Plasmids V482, pFL117 and pC102 contain the DNA
sequences coding for variant V482 RNA, M1 RNA and mutant
C102, respectively, driven by the T7 RNA polymerase promoter
[19,24,31]. Mutant ribozyme C102 contains several point
mutations at the catalytic domain (P4 helix). The DNA sequence
coding for ribozyme TK1, which targets the mRNA of thymi-
dine kinase of HSV-1, has been described [31]. The DNA
sequence encoding ribozyme SCP1 was constructed by PCR
with V482 as the template. The 59 and 39 PCR primers
were AF25 (59-GGAATTCTAATACGACTCACTATAG-39)
and M1SCP1 (59-CCCGCTCGAGAAAAAATGGTGCTGAG-
CAAGTATACGCGTGTGGAATTGTG-39), respectively. The
DNA sequence coding for ribozyme SCP2 was constructed
by introducing into the DNA sequence coding ribozyme
SCP1 with the point mutations (A347C348RC347U348 and
C353C354C355G356RG353G354A355U356) that were found in
C102 and were shown to abolish the ribozyme activity
[19,24,31]. The procedures for in vitro cleavage and binding
analyses were carried out as described previously [24].
Construction of ribozyme-expressing cells
The DNA sequences encoding the ribozymes were subcloned
into retroviral vector LXSN and placed under the control of the
U6 RNA promoter. The retroviral DNA containing the ribozyme
sequence was transfected into human U373MG cells, using
protocols modified from Miller and Rosman [32]. After 48–72 h
Figure 4. Ribozyme-mediated inhibition of HCMV SCP expression and viral growth. (A) Northern analysis of HCMV mRNAs in infected
cells. RNA samples were isolated from parental U373MG cells (lanes 1, 2, 5 and 6) or M1GS-expressing cells (lanes 3, 4, 7 and 8) that were either mock-
infected (lanes 1 and 5) or infected with HCMV (MOI = 0.5–1; all other lanes) for 48 h, separated by denaturing gels, and transferred to membranes.
Membranes were hybridized with radiolabled probes containing the sequence of HCMV SCP mRNA (lanes 1–4) or IE 5 kb RNA (lanes 5–8). SCP1,
ribozyme targeting HCMV SCP mRNA for degradation; SCP2, control ribozyme that binds but cannot degrade HCMV SCP mRNA. (B) Growth of HCMV
in U373MG cells and cell lines expressing M1GS RNA. Cells (56105) were infected with HCMV at MOI = 3. Values are means derived from triplicate
experiments. Standard deviation is indicated by error bars. TK1, control ribozyme targeting HSV-1 thymidine kinase mRNA. (C) Western analysis of
HCMV SCP and MCP proteins. Protein samples were either isolated from the parental U373MG cells or ribozyme-expressing cells (Infected cells, lanes
9–12) or from viral particle preparations purified from these cells (HCMV particles, lanes 13–15), separated in SDS-polyacrylamide gels, transferred to
membranes, and reacted with antibodies against HCMV SCP (anti-SCP) and MCP (anti-MCP) [24].
doi:10.1371/journal.ppat.1003525.g004
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of transfection, cells were incubated in culture medium containing
600 mg/ml neomycin. Cells were subsequently selected in the
presence of neomycin for 2 weeks, and neomycin-resistant cells
were cloned [24].
Northern and Western analyses of viral gene expression
Cells (n = 16106) were either mock-infected or infected with
HCMV at an MOI of 0.05–5 in 1.5 ml DMEM supplemented
with 1% FBS. After 2 h incubation, the inoculum was replaced
with DMEM supplemented with 10% (v/v) FBS. The infected
cells were incubated for 4–72 h and total cellular RNA or protein
was isolated from the cells as described previously [24]. Protein
samples were also prepared from HCMV particles purified from
the infected cells. The RNA fractions were separated in
formaldehyde-containing 1% agarose gels, transferred to a
nitrocellulose membrane, hybridized with 32P-radiolabeled RNA
probes containing the HCMV sequences, and analyzed with a
STORM840 PhosphorImager. The RNA probes used to detect
M1GS RNA, HCMV IE 5-kb RNA transcript, and SCP mRNA
were synthesized from plasmids pFL117, Cig27, and pSCP,
respectively [24,33]. RNA probes were in vitro synthesized and
radiolabeled using an in vitro RNA synthesis kit (Promega, Inc,
Madison, IN).
In Western analysis experiments, protein samples were sepa-
rated on SDS/7.5% polyacrylamide gels cross-linked with
N,N0methylenebisacylamide, and then transferred electrically to
nitrocellulose membranes. We stained the membranes using the
antibodies against HCMV proteins in the presence of a
chemiluminescent substrate (GE Healthcare), and analyzed the
stained membranes with a STORM840 phosphorimager [24].
Quantitation was performed in the linear range of RNA and
protein detection.
Assays for inhibition of viral replication
Cells (n = 16105) were infected with HCMV at MOI values
specified in the Results section. The cells and medium were
harvested at 1-day intervals throughout the 7 days after infection.
Viral stocks were prepared by adding an equal volume of 10%
(v/v) skim milk, followed by sonication. The titers of the viral
stocks were determined by infecting 16105 human foreskin
fibroblasts and counting the number of plaques 10–14 days after
infection [24]. The values obtained were averages from triplicate
experiments.
Purification of SCP-deficient viral particles
Ribozyme SCP1-expressing U373MG cells were infected with
wild type HCMV at MOI = 1–5. After 2 hr incubation, the
medium was replaced with fresh DMEM plus 10% FBS to remove
any free, extracellular viral particles. At 4 days post infection, viral
particles were purified using the same procedure as described
above for the wild type HCMV virion. Due to the significantly
lower viral yield in SCP1-expressing cells, no clear light-scattering
bands were visible in the density gradient. We therefore collected
the fraction of the gradient corresponding to the range encom-
passing the three bands visible in the wild type virion purification.
This fraction was diluted in PBS and centrifuged at 80,000 g for
1 hr to pellet SCP-deficient viral particles. The pellet was then
resuspended in 10 ml PBS, verified by negative staining electron
microscopy to contain viral particles, and used for cryoEM sample
preparation. The remainder gradient was also collected in
fractions of 3 ml each. Each fraction was diluted with PBS,
pelleted, resuspended in 10 ml PBS, and checked individually with
negative staining electron microscopy to confirm the absence of
viral particles.
CryoEM imaging and data processing
An aliquot of 2.5 ml purified sample was applied to a 300 mesh
Quantifoil R1.2/1.3 grid, blotted with filter paper, and plunge-
frozen in liquid ethane. CryoEM images were collected at liquid
nitrogen temperature in an FEI Titan Krios cryo electron
microscope operated at 300 kV with parallel illumination. The
wild type HCMV virion and SCP-deficient HCMV particle
images were recorded on a Gatan 4k64k charge-coupled
device (CCD) camera at an effective magnification of 97, 4986
(nominal magnification 59, 0006 on film plane), corresponding
to an effective pixel size of 1.538 A˚/pixel at the specimen
level. The HCMV capsid images were recorded on Kodak
SO-163 films at a magnification of 59,0006 and micrographs
were digitized with Nikon Coolscan 9000ED scanner at a step size
of 6.35 mm/pixel, giving a pixel size of 1.076 A˚/pixel on
specimen. In all cases, the electron dosage used in cryoEM
imaging was ,25e2/A˚2. The defocus values were determined
with CTFFIND [34] and are in the range of 0.5 mm to 3 mm
underfocus.
Data processing and 3D reconstructions were accomplished
with IMIRS [35,36]. Orientation and center parameters of each
particle were refined against projections computed from 3D
reconstructions in an iterative procedure until no further
improvement in the reconstruction was obtained. Particles were
selected based on the phase residues between the images and the
projections. 3D reconstruction was obtained using the symmetry-
adapted spherical harmonics method [36]. The final capsid and
virion reconstructions were obtained by averaging 20,502 particles
(selected from 37,460 capsid images) and 11,863 particles (selected
from 56,297 virion images), respectively.
Visualization and averaging of density maps were carried out
with UCSF Chimera [37]. Density regions to be averaged were
segmented out as density cubes of similar size. These density cubes
were then first manually aligned and subsequently computation-
ally aligned by the ‘‘fit in map’’ function of Chimera. Averaged
density was produced by executing the ‘‘vop add’’ command on
the above aligned density cubes.
Secondary structure prediction of pp150 was performed with
PSIPRED using the Protein Structure Prediction Server [38].
Data deposition
The cryoEM density maps of the capsid, the virion, and the
SCP-deficient particles have been deposited in the Electron
Figure 5. Confirmation of the role of SCP by structural comparison of SCP-deficient and wild-type viral particles. (A) Representative
cryoEM images of SCP-deficient viral particles showing enveloped particles without the dsDNA genome. (B, C) Radially colored surface
representations of 3D reconstructions of wild type (B) and SCP-deficient (C) HCMV viral particles at 20 A˚ resolution. Lower panels are zoom-in views of
the region containing a triplex, revealing that pp150 is present in the wild-type structure but absent in the SCP-deficient viral particles. (D, E) 15 A˚-
thick central slices extracted from reconstructions of wild type (D) and SCP-deficient (E) particles respectively. Concentric shells of density inside the
capsid in (D) are attributable to the viral dsDNA genome, and they are uniformly spaced (23 A˚). A ring of scaffold densities are identified in (E), but
there is no DNA density. Small bulge on tip of MCP in (D) corresponds to the density of SCP. There is no such bulge at the corresponding position in
the SCP-deficient reconstruction.
doi:10.1371/journal.ppat.1003525.g005
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Microscopy Data Bank (EMDB) (accession code 5695, 5696 and
5697, respectively).
Supporting Information
Figure S1 FSC plots of HCMV capsid and virion
reconstructions. Based on the FSC = 0.143 criterion, the
resolution for the capsid reconstruction is measured to be 6.0 A˚
and that for the virion reconstruction is 8.3 A˚.
(TIF)
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